Healthcare Price Transparency and Its Market Impact: Where Are We Now and What’s Next?
Over the last few years, dual pieces of federal legislation have attempted to curb costs in the healthcare industry: one aimed at hospitals and another targeting insurers. While the initial efficacy of the rules is yet to be determined, the rules have set a new tone and precedent in the U.S. healthcare industry — namely, that government entities at the federal and state levels are taking a more intentional approach to monitoring and controlling costs impacting consumers. A call for shedding light on price variability, coupled with an industry that is increasingly consumer-focused, is driving greater examination of how hospitals, payors and providers price and charge for care.
A&M Healthcare Industry Group Senior Director, Christina Steiner, discusses hospital and payor price transparency and its market impact in a recent article featured in Corporate Compliance Insights.
